Skip to main content

World first in the Switzerland Innovation Park Basel Area

| News

World first in the Switzerland Innovation Park Basel Area


Eldico Scientific has opened the world’s first experience center for electron diffractometry in the site Allschwil of the Switzerland Innovation Park Basel Area. The startup’s innovative device offers advanced nanoanalytic measurement results that have thus far been unattainable, among others for the pharmaceutical industry.

Measuring a sample in the electron diffractometer takes less than one minute (img: Eve Kaiser)

The world’s first experience center for electron diffractometry has started operation in Allschwil. The Switzerland Innovation Park Basel Area is the world’s first site of this new measurement instrument. It was developed by Eldico Scientific, a company founded in 2019 that is located at the Paul Scherrer Institute in Villigen, with which it collaborates closely.

According to a press release from Eldico, the Basel Area is “the right location” for the installation of the world’s first electron diffractometer due to the particularly high density of potential users. Its nanotechnology is implemented in the early phases of new drug development. It enables the spatial representation of molecules, showing the atomic structure of substances that are being investigated with regard to their suitability for medical development. However, the electron diffractometer is also useful for electromobility, specialty chemicals, and new materials.

Important clients with long-term contracts

To date, these visual representations have only been possible with x-ray technology or with an electron microscope. Both options are complex, slow, and expensive. Unlike an electron microscope, which is large and costs 4 million Swiss francs, the Eldico machine is priced at 1.8 million Swiss francs, is significantly smaller, and works much more quickly.

Among the clients with a long-term contract with the experience center in Allschwil is an academic-industrial consortium, consisting of RocheIdorsiaBoerhinger-Ingelheim from Germany, and the Swiss Nanoscience Institute of the University of Basel.

Dr. Christof Klöpper, CEO of the location promotion association Basel Area Business & Innovation, states: “This platform has huge potential to further enhance the life science innovation ecosystem in the region. This is why we are delighted that Eldico Scientific came to us with the idea and that we were able to support this initiative from the very start.” Basel Area Business & Innovation operates the Switzerland Innovation Park Basel Area.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.